Nutex Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	879.95	875.26	479.95	247.65	219.29	331.53
Revenue Growth	40.95%	82.36%	93.80%	12.93%	-33.85%	20.98%
Cost of Revenue	462.28	430.98	283.69	212.87	203.87	152.25
Gross Profit	417.67	444.28	196.26	34.77	15.42	179.28
Selling, General & Admin	141.44	168.66	58.48	36.11	23.89	9.02
Other Operating Expenses	-	-	7.08	30.44	398.14	-
Total Operating Expenses	141.44	168.66	65.56	66.55	422.02	9.02
Operating Income	276.23	275.63	130.7	-31.77	-406.6	170.26
Interest Expense	-20.79	-22.23	-19.93	-16.32	-12.49	-6.2
Other Non-Operating Income (Expense)	5.32	8.62	0.94	0.4	0.56	-5.42
Total Non-Operating Income (Expense)	-15.47	-13.61	-18.99	-15.92	-11.93	-11.62
Pretax Income	250.13	244.78	109.83	-48.49	-419.65	169.49
Provision for Income Taxes	57.81	64.42	15.02	-5.07	13.09	0.97
Net Income	192.31	180.36	94.81	-43.42	-432.74	168.53
Minority Interest in Earnings	95.94	109.57	42.71	2.36	-7.96	35.93
Net Income to Common	96.38	70.79	52.1	-45.79	-424.78	132.59
Net Income Growth	30.81%	35.88%	-	-	-	25.12%
Shares Outstanding (Basic)	7	6	5	4	-	-
Shares Outstanding (Diluted)	7	7	5	4	-	-
Shares Change	16.82%	23.03%	24.57%	-	-	-
EPS (Basic)	13.86	11.13	10.23	-10.39	-	-
EPS (Diluted)	13.86	10.48	9.69	-10.39	-	-
EPS Growth	11.97%	8.15%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	269.02	245.6	20.85	-8.24	35.97	136.51
Free Cash Flow Growth	287.45%	1077.99%	-	-	-73.65%	435.68%
Free Cash Flow Per Share	38.70	36.35	3.80	-1.87	-	-
Gross Margin	47.47%	50.76%	40.89%	14.04%	7.03%	54.08%
Operating Margin	31.39%	31.49%	27.23%	-12.83%	-185.41%	51.36%
Profit Margin	21.86%	20.61%	19.75%	-17.53%	-197.33%	50.83%
FCF Margin	30.57%	28.06%	4.34%	-3.33%	16.40%	41.17%
EBITDA	297.16	296.16	149.67	-14.18	-393.47	177.93
EBITDA Margin	33.77%	33.84%	31.18%	-5.73%	-179.42%	53.67%
EBIT	276.23	275.63	130.7	-31.77	-406.6	170.26
EBIT Margin	31.39%	31.49%	27.23%	-12.83%	-185.41%	51.36%
Effective Tax Rate	23.11%	26.32%	13.68%	10.45%	-3.12%	0.57%

SEC Filings: 10-K · 10-Q